NCT00938496已完成不适用
A Non-interventional Study of Postoperative Treatment With Goserelin Acetate (Zoladex) in Moderate to Severe Endometriosis Patient
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 408
- 试验地点
- 1
- 主要终点
- Symptom recurrence rate and total recurrence rate
研究概览
简要总结
This is a prospective, open label NIS, which is to assess the efficacy of Zoladex in adjuvant setting after operation in moderate to severe endometriosis patients.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Advanced endometriosis confirmed histologically (r-AFS score III-IV) with conservative laparoscopy or laparotomy.
- •Patient who has the indication of Zoladex and has been prescribed Zoladex according to physician's judgement, irrespective of the inclusion in the study.
- •Patient has been already prescribed Zoladex within 1 month after operation.
排除标准
- •Have used hormone treatment prior to 3 months of recruitment.
- •Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
- •Previous enrolment in the present study.
结局指标
主要结局
Symptom recurrence rate and total recurrence rate
时间窗: 18 months
次要结局
- Pregnancy rate(18 months)
- Zoladex administration time(6 months)
- Add-back therapy information(18 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.2 Years PSA Recurrence RateNCT01123434AstraZeneca200
已完成
不适用
A randomized phase II trial of postoperative adjuvant therapy with imanitib for 1 Year versus 6 months in patients with gastrointestinal stromal tumorsGastrointestinal stromal tumor (GIST)JPRN-UMIN000000950Kinki GIST Study Group80
已完成
1 期
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
已完成
2 期
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerBreast CancerBreast DiseaseNeoplasmsNeoplasms by SiteNCT01472146Susanne Crocamo58
进行中（未招募）
2 期
Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.Localized Oesogastric AdenocarcimonaMSI and or dMMRNCT04006262GERCOR - Multidisciplinary Oncology Cooperative Group32